US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

The Illinois Department of Public Health (IDPH) announced although respiratory illness levels dipped for a week, they ...

Stay home if they are sick until they no longer have a fever for 24 hours without using fever-reducing medicine. Return to ...

To accommodate an influx of patients suffering from respiratory illnesses, Union Health has installed a portable medical tent ...

The attack on sick pay on the pretext of “work-shyness” is cynical and dishonest. The same corporations and politicians ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...

Something else to pay attention to is how the child is breathing, which could indicate the infection has moved.

Febrile infants aged 22 to 60 days were less likely to be hospitalized or receive antibiotics after the AAP published updated ...